Core Viewpoint - The company has entered into an investment agreement to acquire additional equity in Yinghe Medical Technology, recognizing the rapid growth potential in the medical imaging AI sector and the increasing demand for precise and efficient imaging diagnostics [1][2][3] Group 1: Investment Details - The company will invest nearly 100 million RMB to subscribe to the new registered capital of Yinghe Medical Technology, which will increase its total equity stake in the company [1] - This investment is part of the company's strategy to enhance its presence in the medical imaging AI sector, aligning with its long-term development plans [2] Group 2: Strategic Importance - The investment is expected to activate a "twin incubation" development mechanism, leveraging the company's quality data resources and Yinghe's AI technology to create a mutually beneficial growth environment [2] - By enhancing its industrial chain layout through this investment, the company aims to transition towards a data-driven service model, improving its core competitive strength in the industry [2] Group 3: Market Positioning - The investment will significantly improve the diagnostic accuracy and efficiency of the company's imaging centers and partner medical institutions, better meeting clinical needs [2] - This strategic move is anticipated to strengthen the company's position in the rapidly growing imaging AI field, allowing it to seize industry development opportunities and achieve sustained business growth [3]

Core Viewpoint - The company has signed a capital increase agreement with Shanghai Yinghe Medical Technology Co., Ltd., investing nearly 100 million RMB to enhance its stake, reflecting a strategic move to strengthen its position in the rapidly growing medical imaging AI sector [1][2]. Group 1: Investment and Strategic Importance - The investment is part of the company's strategy to implement a three-in-one model of medical imaging AI, which includes medical imaging data, AI foundational models, and imaging center scenarios [2]. - This capital connection is expected to activate a "twin incubation" development mechanism, leveraging the company's accumulated quality data resources and Yinghe Medical's AI technology to create a mutually beneficial development cycle [2][3]. Group 2: Market Position and Competitive Advantage - The investment will enhance the company's industrial chain layout, improve service quality, and strengthen its competitive position in the fast-growing imaging AI field [2][3]. - By utilizing Yinghe Medical's technological advantages, the company aims to transition towards a data-driven service model, thereby increasing its core competitiveness in the industry [2]. - The anticipated outcome of this investment is to solidify the company's leadership position in China's medical imaging AI sector through the construction of a comprehensive "data + algorithm + scenario" closed-loop system [3].

Core Viewpoint - The company has entered into a capital increase agreement with Shanghai Yinghe Medical Technology Co., Ltd., investing nearly 100 million RMB to enhance its stake, reflecting a strategic move to strengthen its position in the rapidly growing medical imaging AI sector [1][2]. Group 1 - The investment aligns with the company's strategy of integrating medical imaging data, AI models, and imaging center scenarios, enhancing its long-term development in the medical imaging field [2]. - The partnership with Yinghe Medical will activate a "twin incubation" mechanism, leveraging the company's quality data resources and Yinghe's AI technology to create a beneficial interaction between information, data, and AI capabilities [2]. - The investment is expected to improve the company's competitive position in the fast-growing imaging AI market, enabling sustained business growth [2][3]. Group 2 - The investment will enhance the company's layout in the medical imaging industry chain, improving the precision and efficiency of imaging diagnostic services [3]. - By utilizing Yinghe's technological advantages, the company aims to transition towards a data-driven service model, thereby increasing its core competitiveness in the industry [2][3]. - The establishment of a "data + algorithm + scenario" closed-loop system will solidify the company's leadership position in China's medical imaging AI sector [3].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522） 自願公告 增資於一家醫學影像人工智能公司 本公告由江西一脈陽光集團股份有限公司（「本公司」或「一脈陽光」），連同其附屬 公司統稱（「本集團」）董事（「董事」）會（「董事會」）自願作出。 董事會欣然宣佈，於2025年10月29日（「簽署日」），本公司與上海影禾醫脈智能科 技有限公司（「影禾醫脈」）及其相關各方訂立《增資認購協議》（「協議」）。據此， 本公司以總代價近億元人民幣認購影禾醫脈的新增註冊資本。本次交易完成後， 本公司於影禾醫脈的持股總權益將進一步提升。 董事會認為，醫學影像人工智能作為醫療科技領域未來的核心發展方向，正迎來 市場需求快速釋放的黃金階段。隨著醫療數字化轉型加速，臨床對精準化、高效 化影像診斷的需求日益迫切，這一領域的市場空間將 ...

Group 1 - AI is rapidly entering the healthcare sector, with various AI-assisted diagnostic technologies maturing and more products attempting to integrate into different healthcare processes [1] - The biggest opportunity AI presents for healthcare is the accessibility of personalized and individualized medical services, but the rapid pace of change poses challenges for regulatory bodies [1] - Current technology reserves allow for the exploration of AI robots performing surgeries autonomously, with human doctors overseeing the process [1] Group 2 - AI technology currently plays a supportive role in clinical decision-making, with final responsibility resting on human doctors [2] - The existing regulatory framework is insufficient to address the fast-evolving AI technologies, necessitating a shift towards a more flexible and open regulatory approach [3] - Collaboration between the industry and government is essential to create a regulatory framework that adapts to new technologies without reverting to outdated systems [3]

Core Insights - AI is rapidly entering the healthcare sector, with various AI-assisted diagnostic technologies maturing and new AI products attempting to integrate into different medical processes [1] - The biggest opportunity AI presents in healthcare is the accessibility of personalized medical services, but the rapid pace of change poses challenges for regulatory bodies [1] - There is a need for a more flexible and democratic regulatory framework to keep pace with the advancements in AI technology [4][5] Group 1: AI Technology in Healthcare - Companies are developing AI products for treating diseases like stroke, with capabilities for AI robots to autonomously perform surgeries under human supervision [2] - AI's ability to integrate diverse data types, such as medical imaging and patient history, allows for the creation of individualized treatment plans, enhancing precision medicine [2] - Current AI technologies primarily serve as decision-support tools, with clinical decisions still needing to be made by human doctors [2][3] Group 2: Regulatory Challenges - The regulatory landscape for AI in healthcare is multi-layered, involving drug regulatory agencies, health systems, and individual physicians, which can slow down the adoption of new technologies [3] - There is a consensus among industry experts that the existing regulatory frameworks are inadequate to address the rapid development of AI technologies [3][4] - A call for a more collaborative approach between the industry and government to establish a robust regulatory framework that prioritizes public safety and ethical standards [4][5]

Group 1 - The central government prioritizes employment stability, emphasizing the need to explore and expand employment opportunities through new industries and ecosystems [1] - The digital economy, represented by platform economies, has a significant impact on employment, with approximately 84 million new employment form workers, accounting for 21% of the total workforce [1] - The Tencent WeChat ecosystem has created over 50 million direct and indirect job opportunities, showcasing the positive role of platform enterprises in stabilizing and promoting employment [1] Group 2 - The application of artificial intelligence (AI) is creating new job opportunities, with a talent gap exceeding 5 million in China, indicating vast potential for new positions [2] - Traditional industries, such as manufacturing, are also experiencing employment growth, particularly in the electric vehicle sector, where job postings for automotive mechanical engineers increased by 40.2% year-on-year [2] - The collaboration between human resources services and manufacturing industries is expected to accelerate high-quality employment and support the development of a modern industrial system [2] Group 3 - The "three new" economy (new industries, new business formats, and new models) is projected to account for over 18% of GDP in 2024, indicating a shift towards innovative and intelligent development across various sectors [3] - There is a call for collaboration across sectors to enhance talent training and services, ensuring that economic growth aligns with employment stability and social welfare [3]